{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T22:42:25Z","timestamp":1785451345426,"version":"3.56.0"},"reference-count":55,"publisher":"American Academy of Pediatrics (AAP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,8,1]]},"abstract":"<jats:title>This Policy Statement was reaffirmed January 2018 and May 2024.<\/jats:title>\n                  <jats:p>The use of cochlear implants is increasingly common, particularly in children younger than 3 years. Bacterial meningitis, often with associated acute otitis media, is more common in children with cochlear implants than in groups of control children. Children with profound deafness who are candidates for cochlear implants should receive all age-appropriate doses of pneumococcal conjugate and Haemophilus influenzae type b conjugate vaccines and appropriate annual immunization against influenza. In addition, starting at 24 months of age, a single dose of 23-valent pneumococcal polysaccharide vaccine should be administered. Before implant surgery, primary care providers and cochlear implant teams should ensure that immunizations are up-to-date, preferably with completion of indicated vaccines at least 2 weeks before implant surgery. Imaging of the temporal bone\/inner ear should be performed before cochlear implantation in all children with congenital deafness and all patients with profound hearing impairment and a history of bacterial meningitis to identify those with inner-ear malformations\/cerebrospinal fluid fistulas or ossification of the cochlea. During the initial months after cochlear implantation, the risk of complications of acute otitis media may be higher than during subsequent time periods. Therefore, it is recommended that acute otitis media diagnosed during the first 2 months after implantation be initially treated with a parenteral antibiotic (eg, ceftriaxone or cefotaxime). Episodes occurring 2 months or longer after implantation can be treated with a trial of an oral antimicrobial agent (eg, amoxicillin or amoxicillin\/clavulanate at a dose of approximately 90 mg\/kg per day of amoxicillin component), provided the child does not appear toxic and the implant does not have a spacer\/positioner, a wedge that rests in the cochlea next to the electrodes present in certain implant models available between 1999 and 2002. \u201cWatchful waiting\u201d without antimicrobial therapy is inappropriate for children with implants with acute otitis media. If feasible, tympanocentesis should be performed for acute otitis media, and the material should be sent for culture, but performance of this procedure should not result in an undue delay in initiating antimicrobial therapy. For patients with suspected meningitis, cerebrospinal fluid as well as middle-ear fluid, if present, should be sent for culture. Empiric antimicrobial therapy for meningitis occurring within 2 months of implantation should include an agent with broad activity against Gram-negative bacilli (eg, meropenem) plus vancomycin. For meningitis occurring 2 months or longer after implantation, standard empiric antimicrobial therapy for meningitis (eg, ceftriaxone plus vancomycin) is indicated. For patients with meningitis, urgent evaluation by an otolaryngologist is indicated for consideration of imaging and surgical exploration.<\/jats:p>","DOI":"10.1542\/peds.2010-1427","type":"journal-article","created":{"date-parts":[[2010,7,26]],"date-time":"2010-07-26T21:50:05Z","timestamp":1280181005000},"page":"381-391","source":"Crossref","is-referenced-by-count":91,"title":["Cochlear Implants in Children: Surgical Site Infections and Prevention and Treatment of Acute Otitis Media and Meningitis"],"prefix":"10.1542","volume":"126","author":[{"given":"Lorry G.","family":"Rubin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blake","family":"Papsin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Committee on Infectious Diseases and Section on Otolaryngology\u2013Head and Neck Surgery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2010,8,1]]},"reference":[{"issue":"23","key":"2024110420504702100_B1","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1056\/NEJMct0706268","article-title":"Cochlear implants for children with severe-to-profound hearing loss","volume":"357","author":"Papsin","year":"2007","journal-title":"N Engl J Med"},{"key":"2024110420504702100_B2","unstructured":"National Institute on Deafness and Other Communication Disorders, National Institutes of Health. Cochlear implants. Available at: www.nidcd.nih.gov\/health\/hearing\/coch.asp. Accessed April 14, 2009"},{"issue":"12","key":"2024110420504702100_B3","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1097\/01.mlg.0000149456.75758.4c","article-title":"Cochlear implant surgery at 12 months of age or younger","volume":"114","author":"James","year":"2004","journal-title":"Laryngoscope"},{"key":"2024110420504702100_B4","doi-asserted-by":"crossref","first-page":"11S","DOI":"10.1097\/AUD.0b013e31803153f8","article-title":"Communication development in children who receive the cochlear implant younger than 12 months: risks versus benefits","volume":"28","author":"Dettman","year":"2007","journal-title":"Ear Hear"},{"issue":"8","key":"2024110420504702100_B5","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1097\/01.mlg.0000172039.26650.9b","article-title":"Cochlear implantation in deaf infants","volume":"115","author":"Miyamoto","year":"2005","journal-title":"Laryngoscope"},{"issue":"10","key":"2024110420504702100_B6","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1097\/MLG.0b013e3180de4d35","article-title":"Infectious complications in pediatric cochlear implants","volume":"117","author":"Hopfenspirger","year":"2007","journal-title":"Laryngoscope"},{"issue":"1","key":"2024110420504702100_B7","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.otohns.2004.02.011","article-title":"Postoperative infection in cochlear implant patients","volume":"131","author":"Cunningham","year":"2004","journal-title":"Otolaryngol Head Neck Surg"},{"key":"2024110420504702100_B8","unstructured":"US Food and Drug Administration. FDA public health notification: Continued risk of bacterial meningitis in children with cochlear implants with a positioner beyond twenty-four months post-implantation. 2\u20086, 2006. Available at: www.fda.gov\/MedicalDevices\/Safety\/AlertsandNotices\/PublicHealthNotifications\/UCM062104. Accessed April 14, 2009"},{"issue":"3","key":"2024110420504702100_B9","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ijporl.2003.10.001","article-title":"Cochlear implantation in children with otitis media: second stage of a long-term prospective study","volume":"68","author":"Luntz","year":"2004","journal-title":"Int J Pediatr Otorhinolaryngol"},{"issue":"6 pt 1","key":"2024110420504702100_B10","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1177\/000348948309200612","article-title":"Experiences with the cochlear implant in preschool children","volume":"92","author":"House","year":"1983","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"2024110420504702100_B11","first-page":"6","article-title":"Otitis media in children following the cochlear implant","author":"House","year":"1985","journal-title":"Ear Hear"},{"key":"2024110420504702100_B12","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1177\/0003489400109S1210","article-title":"Mastoiditis and acute otitis media in children with cochlear implants: recommendations for medical management","volume":"185","author":"Kempf","year":"2000","journal-title":"Ann Otol Rhinol Laryngol Suppl"},{"issue":"5","key":"2024110420504702100_B13","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.ijporl.2005.10.001","article-title":"Acute otitis media and mastoiditis following cochlear implantation","volume":"70","author":"Migirov","year":"2006","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"2024110420504702100_B14","first-page":"55","article-title":"Histopathology of cochlear implants: safety considerations","volume-title":"Cochlear Implants","author":"Leake","year":"1985"},{"issue":"3","key":"2024110420504702100_B15","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/00129492-200405000-00010","article-title":"Histologic evaluation of the tissue seal and biologic response around cochlear implant electrodes in the human","volume":"25","author":"Nadol","year":"2004","journal-title":"Otol Neurotol"},{"issue":"9","key":"2024110420504702100_B16","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1097\/00005537-200109000-00023","article-title":"Cochlear implantation in healthy and otitis-prone children: a prospective study","volume":"111","author":"Luntz","year":"2001","journal-title":"Laryngoscope"},{"issue":"5","key":"2024110420504702100_B17","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1056\/NEJMoa031101","article-title":"Risk of bacterial meningitis in children with cochlear implants","volume":"349","author":"Reefhuis","year":"2003","journal-title":"N Engl J Med"},{"issue":"2","key":"2024110420504702100_B18","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1542\/peds.2005-0824","article-title":"Bacterial meningitis among children with cochlear implants beyond 24 months after implantation","volume":"117","author":"Biernath","year":"2006","journal-title":"Pediatrics"},{"issue":"11","key":"2024110420504702100_B19","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1097\/00005537-199611000-00018","article-title":"Otitis media in children with cochlear implants","volume":"106","author":"Luntz","year":"1996","journal-title":"Laryngoscope"},{"issue":"3","key":"2024110420504702100_B20","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/00005537-199903000-00026","article-title":"Otogenic intracranial infections in adults","volume":"109","author":"Barry","year":"1999","journal-title":"Laryngoscope"},{"issue":"6","key":"2024110420504702100_B21","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1159\/000067579","article-title":"Meningitis following cochlear implantation: pathomechanisms, clinical symptoms, conservative and surgical treatments","volume":"64","author":"Arnold","year":"2002","journal-title":"ORL J Otorhinolaryngol Relat Spec"},{"issue":"4","key":"2024110420504702100_B22","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1001\/archotol.124.4.462","article-title":"Histopathological features of a cochlear implant and otogenic meningitis in Mondini dysplasia","volume":"124","author":"Suzuki","year":"1998","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"8","key":"2024110420504702100_B23","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.ijporl.2004.03.009","article-title":"Recurrent acute otitis media associated meningitis in a patient with a contralateral cochlear implant and bilateral cochleovestibular dysplasia","volume":"68","author":"Belmont","year":"2004","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"2024110420504702100_B24","first-page":"20","article-title":"Bacterial meningitis among cochlear implant recipients: Canada, 2002","volume":"55","author":"Centers for Disease Control and Prevention","year":"2006","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"2024110420504702100_B25","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1086\/524083","article-title":"Can we prevent cochlear implant recipients from developing pneumococcal meningitis?","volume":"46","author":"Wei","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"3","key":"2024110420504702100_B26","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.otohns.2006.10.008","article-title":"Hearing loss diagnosis followed by meningitis in Danish children, 1995\u20132004","volume":"136","author":"Parner","year":"2007","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"8","key":"2024110420504702100_B27","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1097\/01.inf.0000136818.94301.db","article-title":"Cochlear implants and meningitis in children: concise reviews of pediatric infectious diseases","volume":"23","author":"Whitney","year":"2004","journal-title":"Pediatr Infect Dis J"},{"issue":"5","key":"2024110420504702100_B28","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1001\/archotol.1990.01870050108018","article-title":"Recurrent meningitis and Mondini dysplasia","volume":"116","author":"Ohlms","year":"1990","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"18","key":"2024110420504702100_B29","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa022823","article-title":"Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine","volume":"348","author":"Whitney","year":"2003","journal-title":"N Engl J Med"},{"issue":"RR-9","key":"2024110420504702100_B30","first-page":"1","article-title":"Preventing pneumococcal disease among infants and young children: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"49","author":"Centers for Disease Control and Prevention","year":"2000","journal-title":"MMWR Recomm Rep"},{"issue":"6","key":"2024110420504702100_B31","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM200102083440602","article-title":"Efficacy of a pneumococcal conjugate vaccine against acute otitis media","volume":"344","author":"Eskola","year":"2001","journal-title":"N Engl J Med"},{"issue":"1","key":"2024110420504702100_B32","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/00006454-200301000-00006","article-title":"Impact of the pneumococcal conjugate vaccine on otitis media","volume":"22","author":"Fireman","year":"2003","journal-title":"Pediatr Infect Dis J"},{"issue":"9376","key":"2024110420504702100_B33","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1016\/S0140-6736(03)13772-5","article-title":"Effect of conjugate pneumococcal vaccine followed by polysaccharide pneumococcal vaccine on recurrent acute otitis media: a randomised study","volume":"361","author":"Veenhoven","year":"2003","journal-title":"Lancet"},{"issue":"3","key":"2024110420504702100_B34","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1542\/peds.2005-0940","article-title":"Effect of combined pneumococcal conjugate and polysaccharide vaccination on recurrent otitis media with effusion","volume":"117","author":"van Heerbeek","year":"2006","journal-title":"Pediatrics"},{"issue":"17\u201318","key":"2024110420504702100_B35","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/S0264-410X(02)00807-1","article-title":"The potential indirect effect of conjugate pneumococcal vaccines","volume":"21","author":"O'Brien","year":"2003","journal-title":"Vaccine"},{"issue":"2 pt 1","key":"2024110420504702100_B36","first-page":"367","article-title":"Technical report: prevention of pneumococcal infections, including the use of pneumococcal conjugate and polysaccharide vaccines and antibiotic prophylaxis","volume":"106","author":"American Academy of Pediatrics, Committee on Infectious Diseases","year":"2000","journal-title":"Pediatrics"},{"issue":"3","key":"2024110420504702100_B37","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1086\/422395","article-title":"Immunogenicity of pneumococcal vaccination of patients with cochlear implants","volume":"190","author":"Rose","year":"2004","journal-title":"J Infect Dis"},{"issue":"09","key":"2024110420504702100_B38","first-page":"258","article-title":"Licensure of a 13-valent pneumococcal conjugate vaccine (PCV13) and recommendations for use among children: Advisory Committee on Immunization Practices (ACIP), 2010","volume":"59","author":"Centers for Disease Control and Prevention","year":"2010","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"20","key":"2024110420504702100_B39","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1056\/NEJM199011153232004","article-title":"A randomized, prospective field trial of a conjugate vaccine in the protection of infants and young children against invasive Haemophilus influenzae type b disease","volume":"323","author":"Eskola","year":"1990","journal-title":"N Engl J Med"},{"issue":"1","key":"2024110420504702100_B40","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/infdis\/171.1.93","article-title":"The impact of conjugate vaccine on carriage of Haemophilus influenzae type b","volume":"171","author":"Barbour","year":"1995","journal-title":"J Infect Dis"},{"issue":"9","key":"2024110420504702100_B41","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1097\/01.mlg.0000171016.82850.41","article-title":"Does the 23-valent pneumococcal vaccine protect cochlear implant recipients?","volume":"115","author":"Hey","year":"2005","journal-title":"Laryngoscope"},{"key":"2024110420504702100_B42","article-title":"Grade definitions","author":"US Department of Health and Human Services, Agency for Healthcare Research and Quality (AHRC)"},{"issue":"1","key":"2024110420504702100_B43","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0165-5876(96)01398-5","article-title":"Otitis media with effusion in paediatric cochlear implantees: the role of peri-implant grommet insertion","volume":"38","author":"Papsin","year":"1996","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"2024110420504702100_B44","doi-asserted-by":"crossref","unstructured":"American Academy of Pediatrics, Committee on Infectious Diseases. Recommended childhood and adolescent immunization schedules\u2013United States, 2008. 2010;125(1):195\u2013196. Available at: http:\/\/pediatrics.aappublications.org\/cgi\/content\/full\/125\/1\/195\/DC1.","DOI":"10.1542\/peds.2009-3194"},{"issue":"41","key":"2024110420504702100_B45","first-page":"931","article-title":"Notice to readers: pneumococcal vaccination for cochlear implant recipients","volume":"51","author":"Centers for Disease Control and Prevention","year":"2002","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"31","key":"2024110420504702100_B46","first-page":"739","article-title":"Pneumococcal vaccination for cochlear implant candidates and recipients: updated recommendations of the Advisory Committee on Infectious Practices","volume":"52","author":"Centers for Disease Control and Prevention, Advisory Committee on Immunization Practices","year":"2003","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"13","key":"2024110420504702100_B47","first-page":"343","article-title":"Update recommendation of the Advisory Committee on Immunization Practices (ACIP) for use of 7-valent pneumococcal conjugate vaccine (PCV7) in children aged 24\u201359 months who are not completely vaccinated","volume":"57","author":"Centers for Disease Control and Prevention, Advisory Committee on Immunization Practices","year":"2008","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"2024110420504702100_B48","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1542\/peds.2005-1314","article-title":"Prevention and control of meningococcal disease: recommendations for use of meningococcal vaccines in pediatric patients","volume":"116","author":"American Academy of Pediatrics, Committee on Infectious Diseases","year":"2005","journal-title":"Pediatrics"},{"issue":"31","key":"2024110420504702100_B49","first-page":"794","article-title":"Notice to readers: revised recommendations of the Advisory Committee on Immunization Practices to vaccinate all persons aged 11\u201318 years with meningococcal conjugate vaccine","volume":"56","author":"Centers for Disease Control and Prevention, Advisory Committee on Immunization Practices","year":"2007","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"48","key":"2024110420504702100_B50","first-page":"1265","article-title":"Notice to readers: recommendation from the Advisory Committee on Immunization Practices (ACIP) for use of quadrivalent meningococcal conjugate vaccine (MCV4) in children aged 2\u201310 years at increased risk for invasive meningococcal disease","volume":"56","author":"Centers for Disease Control and Prevention","year":"2007","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"10","key":"2024110420504702100_B51","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1001\/archpedi.1995.02170230067009","article-title":"Influenza A vaccine decreases the incidence of otitis media in 6- to 30-month-old children in day care","volume":"149","author":"Clements","year":"1995","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"4","key":"2024110420504702100_B52","first-page":"445","article-title":"Influenza vaccination in the prevention of acute otitis media in children","volume":"145","author":"Heikkinen","year":"1991","journal-title":"Am J Dis Child"},{"issue":"12","key":"2024110420504702100_B53","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1001\/jama.290.12.1608","article-title":"Effectiveness of inactivated influenza vaccine in preventing acute otitis media in young children: a randomized controlled trial","volume":"290","author":"Hoberman","year":"2003","journal-title":"JAMA"},{"issue":"5","key":"2024110420504702100_B54","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/01.inf.0000217370.83948.51","article-title":"Effectiveness of inactivated influenza vaccine for prevention of otitis media in children","volume":"25","author":"Ozgur","year":"2006","journal-title":"Pediatr Infect Dis J"},{"issue":"5","key":"2024110420504702100_B55","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1542\/peds.113.5.1451","article-title":"Diagnosis and management of acute otitis media","volume":"113","author":"American Academy of Pediatrics, Subcommittee on Management of Acute Otitis Media","year":"2004","journal-title":"Pediatrics"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/126\/2\/381\/1733388\/zpe00810000381.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/126\/2\/381\/1733388\/zpe00810000381.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T15:51:02Z","timestamp":1730735462000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/126\/2\/381\/68536\/Cochlear-Implants-in-Children-Surgical-Site"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8,1]]},"references-count":55,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2010,8,1]]},"published-print":{"date-parts":[[2010,8,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2010-1427","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.4781956.4684054","asserted-by":"object"}]},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,8,1]]}}}